High-dose thiotepa and melphalan with hemopoietic progenitor support following induction therapy with epirubicin-paclitaxel-containing regimens in metastatic breast cancer (MBC).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples